Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.52
+0.16 (1.91%)
At close: Oct 24, 2025, 4:00 PM EDT
8.49
-0.03 (-0.35%)
After-hours: Oct 24, 2025, 7:59 PM EDT
Novavax Market Cap
Novavax has a market cap or net worth of $1.38 billion as of October 24, 2025. Its market cap has decreased by -31.83% in one year.
Market Cap
1.38B
Enterprise Value
1.00B
1-Year Change
-31.83%
Ranking
Category
Stock Price
$8.52
Market Cap Chart
Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.38B, an increase of 5,284.56%. That is a compound annual growth rate of 15.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 1.38B | 7.45% |
| Dec 31, 2024 | 1.29B | 125.87% |
| Dec 29, 2023 | 570.20M | -29.34% |
| Dec 30, 2022 | 807.00M | -92.54% |
| Dec 31, 2021 | 10.82B | 52.38% |
| Dec 31, 2020 | 7.10B | 6,609.55% |
| Dec 31, 2019 | 105.80M | -84.98% |
| Dec 31, 2018 | 704.40M | 81.13% |
| Dec 29, 2017 | 388.90M | 13.78% |
| Dec 30, 2016 | 341.80M | -84.90% |
| Dec 31, 2015 | 2.26B | 60.10% |
| Dec 31, 2014 | 1.41B | 32.47% |
| Dec 31, 2013 | 1.07B | 281.83% |
| Dec 31, 2012 | 279.60M | 92.96% |
| Dec 30, 2011 | 144.90M | -46.33% |
| Dec 31, 2010 | 270.00M | 8.56% |
| Dec 31, 2009 | 248.70M | 90.28% |
| Dec 31, 2008 | 130.70M | -36.71% |
| Dec 31, 2007 | 206.50M | -18.35% |
| Dec 29, 2006 | 252.90M | 33.74% |
| Dec 30, 2005 | 189.10M | 46.70% |
| Dec 31, 2004 | 128.90M | -28.82% |
| Dec 31, 2003 | 181.10M | 182.53% |
| Dec 31, 2002 | 64.10M | -80.46% |
| Dec 31, 2001 | 328.10M | 97.53% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |